Table: Modalis Therapeutics -2020 group forecast
Dec 15 (Reuters) -
Modalis Therapeutics Corporation
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2020 Dec 31, 2020
LATEST PREVIOUS
FORECAST FORECAST
Sales 342 mln 1.10
Operating loss 420 mln 350 mln
Recurring loss 463 mln 300 mln
Net loss 471 mln 250 mln
EPS loss 17.89 yen 9.63 yen
NOTE - Modalis Therapeutics Corporation.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T